| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.099 | 0.03 |